ライフサイエンスコーパス: Neisseria gonorrhoeae

1 ts Chlamydia trachomatis and "GC" represents Neisseria gonorrhoeae).

2 o the fiber model of the type IVa pilin from Neisseria gonorrhoeae.

3 n complicated by antimicrobial resistance in Neisseria gonorrhoeae.

4 Gen-Probe Aptima assays for the detection of Neisseria gonorrhoeae.

5 ricted set of Gram-negative bacteria such as Neisseria gonorrhoeae.

6 dressed this question for the human pathogen Neisseria gonorrhoeae.

7 in the sexually transmitted disease pathogen Neisseria gonorrhoeae.

8 egative pathogens Pseudomonas aeruginosa and Neisseria gonorrhoeae.

9 neous detection of Chlamydia trachomatis and Neisseria gonorrhoeae.

10 etic exchange in the obligate human pathogen Neisseria gonorrhoeae.

11 fection by the sexually transmitted pathogen Neisseria gonorrhoeae.

12 m cephalosporins ceftriaxone and cefixime in Neisseria gonorrhoeae.

13 variable pilin locus of the human pathogen, Neisseria gonorrhoeae.

14 he more common sexually transmitted pathogen Neisseria gonorrhoeae.

15 nts such as human immunodeficiency virus and Neisseria gonorrhoeae.

16 xposure to the sexually transmitted pathogen Neisseria gonorrhoeae.

17 f gene transcription in the mucosal pathogen Neisseria gonorrhoeae.

18 terial infections: Chlamydia trachomatis and Neisseria gonorrhoeae.

19 or tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae.

20 n occurred on yeast cell walls (zymosan) and Neisseria gonorrhoeae.

21 ing Leishmania major, Trypanosoma cruzi, and Neisseria gonorrhoeae.

22 antigens for inclusion in a vaccine against Neisseria gonorrhoeae.

23 llows it to modulate biofilm accumulation by Neisseria gonorrhoeae.

24 ce and global spread of antibiotic-resistant Neisseria gonorrhoeae.

25 c inflammation that is insufficient to clear Neisseria gonorrhoeae.

26 l with substantial in vitro activity against Neisseria gonorrhoeae.

27 to date has examined the effects of CrgA in Neisseria gonorrhoeae.

28 r survival and establishment of infection by Neisseria gonorrhoeae.

29 ases (LDHs) from the obligate human pathogen Neisseria gonorrhoeae.

30 ons due to suspected cephalosporin-resistant Neisseria gonorrhoeae.

31 eningitidis isolate containing one copy of a Neisseria gonorrhoeae 16S rRNA gene is described herein.

32 s demonstrated with the analysis of clinical Neisseria gonorrhoeae 16S rRNA to show its potential val

33 We previously demonstrated that Neisseria gonorrhoeae, a Gram-negative pathogen responsi

34 Neisseria gonorrhoeae acetylates its cell wall peptidogl

35 Mycoplasma genitalium was associated with Neisseria gonorrhoeae (adjusted OR, 1.84; 95% CI, 1.13-2

36 cillus crispatus, Gardnerella vaginalis, and Neisseria gonorrhoeae All vaginal microbiota and N. gono

37 Neisseria gonorrhoeae and Chlamydia trachomatis are well

38 lis by vaginal swabs; NAATs for detection of Neisseria gonorrhoeae and Chlamydia trachomatis from pha

39 ed amplification (TMA) enhances detection of Neisseria gonorrhoeae and Chlamydia trachomatis from rec

40 challenging the validity of the low-positive Neisseria gonorrhoeae and Chlamydia trachomatis results

41 f patient gender, specimen source, molecular Neisseria gonorrhoeae and Chlamydia trachomatis results,

42 Genital tract infections caused by Neisseria gonorrhoeae and Chlamydia trachomatis serovars

43 , and urethral/first-void urine samples) for Neisseria gonorrhoeae and Chlamydia trachomatis using nu

44 simplex virus type 2, and were screened for Neisseria gonorrhoeae and Chlamydia trachomatis.

45 alternative pathway of complement, binds to Neisseria gonorrhoeae and constitutes an important mecha

46 Molecular typing of Neisseria gonorrhoeae and contact tracing provide a comb

47 is the primary subunit of type IV pili from Neisseria gonorrhoeae and contains a surface-exposed hyp

48 termined the crystal structures of MltA from Neisseria gonorrhoeae and Escherichia coli (NgMltA and E

49 e BAM complex, from two species of bacteria: Neisseria gonorrhoeae and Haemophilus ducreyi.

50 ly related bacteria, Neisseria meningitidis, Neisseria gonorrhoeae and Neisseria lactamica, which exh

51 (Lst) is expressed on the outer membrane of Neisseria gonorrhoeae and Neisseria meningitidis and sia

52 Neisseria gonorrhoeae and Neisseria meningitidis are clo

53 Neisseria gonorrhoeae and Neisseria meningitidis both ex

54 terized pilin antigenic variation systems of Neisseria gonorrhoeae and Neisseria meningitidis is pres

55 an-adapted Neisseria includes two pathogens, Neisseria gonorrhoeae and Neisseria meningitidis, and at

56 Two human pathogens, Neisseria gonorrhoeae and Neisseria meningitidis, stimul

57 PNAG is also a capsular polysaccharide for Neisseria gonorrhoeae and nontypable Hemophilus influenz

58 ction of an intense inflammatory response by Neisseria gonorrhoeae and the persistence of this pathog

59 irth outcome (OR, 0.24; 95% 0.09, 0.66), and Neisseria gonorrhoeae and/or Chlamydia trachomatis had 9

60 ain (ATD) from the bifunctional enzyme PglB (Neisseria gonorrhoeae) and the full-length acetyltransfe

61 li, Salmonella enterica serovar Typhimurium, Neisseria gonorrhoeae, and Haemophilus ducreyi and deter

62 s, type-specific human papillomavirus (HPV), Neisseria gonorrhoeae, and HIV antibody.

63 on effect on incident Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium infecti

64 g Staphylococcus aureus, Bacillus anthracis, Neisseria gonorrhoeae, and Neisseria meningitidis.

65 ions for Escherichia coli, Haemophilus spp., Neisseria gonorrhoeae, and Pasteurella multocida.

66 fluoroquinolone-resistant Campylobacter spp, Neisseria gonorrhoeae, and Salmonella typhi were include

67 ycoplasma genitalium, Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis in liqu

68 and were screened for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis infecti

69 M. genitalium and for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis Sequenc

70 e urine specimens for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis via com

71 In this study, we predicted Neisseria gonorrhoeae Ape1a to be an SGNH hydrolase with

72 to test the hypothesis that multiple pili of Neisseria gonorrhoeae are coordinated through a tug-of-w

73 Infections by Neisseria gonorrhoeae are increasingly common, are often

74 pic pregnancy, and Chlamydia trachomatis and Neisseria gonorrhoeae are recognized microbial causes.

75 s of com genes in Haemophilus influenzae and Neisseria gonorrhoeae, are necessary for the use of extr

76 Type IV pili are required for virulence in Neisseria gonorrhoeae, as they are involved in adherence

77 Candida albicans, Gardnerella vaginalis, and Neisseria gonorrhoeae, as well as to toxic shock syndrom

78 y different NAATs (SDA, PCR, AC2, and Aptima Neisseria gonorrhoeae assay [AGC]; Gen-Probe Inc.).

79 , 0.06 to 0.5 microg/ml and 23 to 31 mm; and Neisseria gonorrhoeae ATCC 49226, 30 to 40 mm.

80 Unlike Neisseria gonorrhoeae, binding of fH to N. meningitidis

81 d method to detect Chlamydia trachomatis and Neisseria gonorrhoeae, but no commercial tests are clear

82 d method to detect Chlamydia trachomatis and Neisseria gonorrhoeae, but no commercial tests are clear

83 r the detection of Chlamydia trachomatis and Neisseria gonorrhoeae by a transcription-mediated amplif

84 s) can block complement-dependent killing of Neisseria gonorrhoeae by otherwise bactericidal Abs.

85 enome assemblies, we analyzed 25 isolates of Neisseria gonorrhoeae by using a high-resolution single

86 th the sexually transmitted disease pathogen Neisseria gonorrhoeae can either inhibit or induce apopt

87 Neisseria gonorrhoeae can engage human complement recept

88 Most strains of Neisseria gonorrhoeae carry the 57-kb gonococcal genetic

89 Neisseria gonorrhoeae causes gonorrhea, a sexually trans

90 Neisseria gonorrhoeae cells (gonococci [GC]), the etiolo

91 STIs examined were laboratory-detected Neisseria gonorrhoeae, Chlamydia trachomatis, and Tricho

92 , and nucleic acid amplification testing for Neisseria gonorrhoeae, Chlamydia trachomatis, and Tricho

93 fic sexually transmitted infections, such as Neisseria gonorrhoeae, Chlamydia trachomatis, HIV, human

94 All participants were tested for Neisseria gonorrhoeae, Chlamydia trachomatis, Treponema

95 flexneri, and Campylobacter jejuni, but not Neisseria gonorrhoeae, cleaved E-cadherin on host cells.

96 the prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae coinfections in U.S. women undergo

97 AGS) in the arginine biosynthetic pathway of Neisseria gonorrhoeae complexed with acetyl-CoA and with

98 Peptidoglycan fragments released by Neisseria gonorrhoeae contribute to the inflammation and

99 In vitro studies have demonstrated that Neisseria gonorrhoeae controls the expression of several

100 r the detection of Chlamydia trachomatis and Neisseria gonorrhoeae developed by Abbott Molecular Inc.

101 ting, this study examined the persistence of Neisseria gonorrhoeae DNA following treatment for pharyn

102 o comprehensively examine the role of NER in Neisseria gonorrhoeae DNA recombination and repair proce

103 The human-restricted pathogen Neisseria gonorrhoeae encodes a single N-acetylmuramyl-l

104 The porin gene (porB) of Neisseria gonorrhoeae encodes the major outer membrane p

105 The type IV secretion system gene cluster of Neisseria gonorrhoeae encodes two peptidoglycan transgly

106 in female mice to study mechanisms by which Neisseria gonorrhoeae evades host-derived antimicrobial

107 Screening assays for Neisseria gonorrhoeae exhibit low positive predictive va

108 Neisseria gonorrhoeae expressing type IV pili (Tfp) acti

109 um and the homologous NgoAVII RM system from Neisseria gonorrhoeae FA1090 are composed of three genes

110 Neisseria gonorrhoeae forms a biofilm in flow cells on g

111 orin variable region [VR] typing) strains of Neisseria gonorrhoeae from an infected male and two of h

112 A redundancy of defenses may protect Neisseria gonorrhoeae from phagocyte-derived reactive ox

113 icated for evaluating UTI (E. coli) and STD (Neisseria gonorrhoeae) from human urine samples.

114 e III as predicted, whereas the hairpin from Neisseria gonorrhoeae functions as an intrinsic transcri

115 O-Acetylpeptidoglycan esterase from Neisseria gonorrhoeae functions to release O-acetyl grou

116 s quantified from rectal swabs collected for Neisseria gonorrhoeae (GC) and Chlamydia trachomatis (CT

117 men who have receptive anal intercourse for Neisseria gonorrhoeae (GC) and Chlamydia trachomatis (CT

118 The obligate human pathogen Neisseria gonorrhoeae (Gc) has co-opted conserved recomb

119 nfections but have rarely been developed for Neisseria gonorrhoeae (GC) infection.

120 Neisseria gonorrhoeae (Gc) is an obligate human pathogen

121 The pilin antigenic variation (Av) system of Neisseria gonorrhoeae (Gc) mediates unidirectional DNA r

122 Neisseria gonorrhoeae (Gc), an obligate human bacterial

123 tal Chlamydia trachomatis (CT) and/or rectal Neisseria gonorrhoeae (GC).

124 on of HD5 and HD6 was induced in response to Neisseria gonorrhoeae (GC, for gonococcus) infection and

125 Clinical studies indicate that Neisseria gonorrhoeae (gonococci (GC)) has the capacity

126 Neisseria gonorrhoeae (gonococcus [GC]), is highly adapt

127 d three of the CDC approaches for confirming Neisseria gonorrhoeae (gonococcus [GC])-positive nucleic

128 rectal Chlamydia trachomatis (chlamydia) and Neisseria gonorrhoeae (gonorrhea) infections in women.

129 Neisseria gonorrhoeae grows anaerobically by anaerobic r

130 Over the past 60 years, Neisseria gonorrhoeae has acquired clinically significan

131 Neisseria gonorrhoeae has been shown to produce biofilms

132 Neisseria gonorrhoeae has developed resistance to each o

133 Neisseria gonorrhoeae has evolved a repertoire of iron a

134 Neisseria gonorrhoeae has two porins, PIA and PIB, whose

135 ns-acting sRNA in Neisseria meningitidis and Neisseria gonorrhoeae, has been shown in the meningococc

136 effects that LOS from 5 different strains of Neisseria gonorrhoeae have on HIV infection and on HIV p

137 ctions of MMC in the obligate human pathogen Neisseria gonorrhoeae, homologues of the core MMC genes

138 mical analyses of Kingella denitrificans and Neisseria gonorrhoeae HpuA mutants, although validating

139 conditions, as well as in the human pathogen Neisseria gonorrhoeae identified HemN as a copper toxici

140 nd of the autotransporter beta-domain of the Neisseria gonorrhoeae IgA protease precursor (IgAbeta),

141 cular detection of Chlamydia trachomatis and Neisseria gonorrhoeae in clinical samples.

142 -sensitive and cefixime-resistant strains of Neisseria gonorrhoeae in MSM in England, which was appli

143 ed a point-of-care test for the detection of Neisseria gonorrhoeae in patients attending a public hea

144 r the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in rectal swabs with regulatory ap

145 ltaneously detects Chlamydia trachomatis and Neisseria gonorrhoeae in swab and first-catch urine (FCU

146 produce hydrogen peroxide (H(2)O(2)) inhibit Neisseria gonorrhoeae in vitro, and clinical data sugges

147 Information on the innate response to Neisseria gonorrhoeae in women is limited to studies wit

148 Studies of Neisseria gonorrhoeae-infected cells with the CD46 tail

149 n is associated with bacterial burden during Neisseria gonorrhoeae infection and alters the infection

150 point-of-care Gram stain testing to diagnose Neisseria gonorrhoeae infection and nongonococcal urethr

151 he main consequences of sexually transmitted Neisseria gonorrhoeae infection and probably involve an

152 imal methods for the diagnosis of pharyngeal Neisseria gonorrhoeae infection are uncertain.

153 Treatment of Neisseria gonorrhoeae infection is empirical and based o

154 ions (syphilis, genital ulcer disease [GUD], Neisseria gonorrhoeae infection, Chlamydia trachomatis i

155 since sexual debut, Chlamydia trachomatis or Neisseria gonorrhoeae infection, hormonal contraceptive

156 acid amplification tests (NAATs) to diagnose Neisseria gonorrhoeae infections complicates the perform

157 osporins are the cornerstone of treatment of Neisseria gonorrhoeae infections, cefixime is the only o

158 g efficacious exposures for the treatment of Neisseria gonorrhoeae infections.

159 Neisseria gonorrhoeae is a common sexually transmitted p

160 Neisseria gonorrhoeae is a human-specific organism that

161 Neisseria gonorrhoeae is a sexually transmitted pathogen

162 Multidrug-resistant Neisseria gonorrhoeae is a top threat to public health.

163 Antimicrobial-resistant Neisseria gonorrhoeae is an emerging public health probl

164 The major outer membrane porin (PorB) of Neisseria gonorrhoeae is an essential protein that media

165 Neisseria gonorrhoeae is an obligate human pathogen that

166 Neisseria gonorrhoeae is an obligate human pathogen that

167 Antimicrobial resistance (AMR) by Neisseria gonorrhoeae is considered a serious global thr

168 ation pathway in PilE antigenic variation in Neisseria gonorrhoeae is contentious and appears to be s

169 f the most frequent infectious diseases, and Neisseria gonorrhoeae is emerging as resistant to most a

170 The strict human pathogen Neisseria gonorrhoeae is exposed to oxidative damage dur

171 ce and spread of antimicrobial resistance in Neisseria gonorrhoeae is globally recognised.

172 The PilB protein from Neisseria gonorrhoeae is located in the periplasm and ma

173 The transferrin iron acquisition system of Neisseria gonorrhoeae is necessary for iron uptake from

174 demonstrated that the strict human pathogen Neisseria gonorrhoeae is polyploid, carrying an average

175 Neisseria gonorrhoeae is prone to undergo autolysis unde

176 he O-linked protein glycosylation pathway in Neisseria gonorrhoeae is responsible for the synthesis o

177 Neisseria gonorrhoeae is the bacterium that causes gonor

178 Neisseria gonorrhoeae is the causative agent of gonorrhe

179 Neisseria gonorrhoeae is the etiologic agent of gonorrhe

180 ea, a sexually transmitted disease caused by Neisseria gonorrhoeae, is an important cause of morbidit

181 The MtrCDE multidrug pump, from Neisseria gonorrhoeae, is assembled from the inner and o

182 We report on the first Neisseria gonorrhoeae isolate in the United States ident

183 The percentage of quinolone-resistant Neisseria gonorrhoeae isolated in London increased betwe

184 In the United States, 19.2% of Neisseria gonorrhoeae isolates are resistant to ciproflo

185 We identified a cluster of Neisseria gonorrhoeae isolates with high-level azithromy

186 The addition of host-derived sialic acid to Neisseria gonorrhoeae lipooligosaccharide is hypothesize

187 Neisseria gonorrhoeae lipooligosaccharides (LOSs) induce

188 perons encoding putative ABC transporters in Neisseria gonorrhoeae MS11.

189 The Neisseria gonorrhoeae MtrC-MtrD-MtrE multidrug-resistanc

190 MtrR represses expression of the Neisseria gonorrhoeae mtrCDE multidrug efflux transporte

191 Neisseria gonorrhoeae multiantigen sequence typing (NG-M

192 Like many bacterial pathogens, Neisseria gonorrhoeae must adapt to environmental change

193 ng the concurrence of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, and Tricho

194 of these peptides to serve as substrates for Neisseria gonorrhoeae (NG) PBP3 was assessed.

195 ous detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and an internal control in t

196 h a network-based mathematical model of HIV, Neisseria gonorrhoeae (NG), and Chlamydia trachomatis (C

197 compares the crystal structures of NAGS from Neisseria gonorrhoeae (ngNAGS) in the inactive T-state w

198 ic compound extrusion transporter, NorM from Neisseria gonorrhoeae (NorM_NG).

199 is, codetection of Chlamydia trachomatis and Neisseria gonorrhoeae occurred in 7.8% and 2.7% of healt

200 the effects of different bacterial doses of Neisseria gonorrhoeae on the cytokine response of primar

201 In Neisseria gonorrhoeae, one of the first bacteria for whi

202 rmed by laboratory isolation or detection of Neisseria gonorrhoeae only from a clinical specimen, and

203 We previously reported that Neisseria gonorrhoeae Opa protein expression appeared to

204 l intercourse or were women at high risk for Neisseria gonorrhoeae or Chlamydia trachomatis infection

205 infections in prepubertal children, such as Neisseria gonorrhoeae or Chlamydia trachomatis, are due

206 associated with endocervical infection with Neisseria gonorrhoeae or Chlamydia trachomatis.

207 ion on infections among men, infections with Neisseria gonorrhoeae or Trichomonas vaginalis, or long-

208 d to be infected with Chlamydia trachomatis, Neisseria gonorrhoeae, or herpes simplex virus type 2.

209 Ps (the LMMA enzymes, Escherichia coli PBP5, Neisseria gonorrhoeae PBP4, and Streptococcus pneumoniae

210 jor outer membrane porin (PorB) expressed by Neisseria gonorrhoeae plays multiple roles during infect

211 In this study we demonstrate that Neisseria gonorrhoeae porin (Por) 1B selectively binds C

212 Molecular methods that characterize the Neisseria gonorrhoeae porin protein Por are needed to st

213 Our results suggest that Neisseria gonorrhoeae possesses the ability to suppress

214 The compound, CGS 15943, targets Neisseria gonorrhoeae PriA helicase with an IC(50) of 11

215 eins, we determined the crystal structure of Neisseria gonorrhoeae PriB at 2.7 A resolution and inves

216 Neisseria gonorrhoeae produces a type IV secretion syste

217 Neisseria gonorrhoeae produces no known siderophores but

218 Neisseria gonorrhoeae produces several antioxidant defen

219 BD ProbeTec Chlamydia trachomatis Q(x) (CTQ)/Neisseria gonorrhoeae Q(x) (GCQ), Hologic Aptima Combo 2

220 Quinolone-resistant Neisseria gonorrhoeae (QRNG) arise from mutations in gyr

221 k in California of fluoroquinolone-resistant Neisseria gonorrhoeae (QRNG) by evaluation of a combinat

222 ce tools to detect fluoroquinolone-resistant Neisseria gonorrhoeae (QRNG) in urine samples.

223 In Neisseria gonorrhoeae, recent work has revealed that Nsr

224 However, for DNA uptake, Neisseria gonorrhoeae recognizes only DNA containing a 1

225 rol groups were immunized i.m. and s.c. with Neisseria gonorrhoeae recombinant porin B (Ng-rPorB) or

226 Both Neisseria meningitidis and Neisseria gonorrhoeae recruit the alternative pathway co

227 The human pathogen Neisseria gonorrhoeae recruits and interacts extensively

228 In contrast, the Neisseria gonorrhoeae RecX protein (RecX(Ng)) enhances a

229 Neisseria gonorrhoeae releases peptidoglycan (PG) fragme

230 Neisseria gonorrhoeae releases peptidoglycan fragments d

231 The closely related pathogen Neisseria gonorrhoeae releases PG fragments during norma

232 Neisseria gonorrhoeae requires iron for survival in the

233 iptome analysis of the facultative anaerobe, Neisseria gonorrhoeae, revealed that many genes of unkno

234 ification test for Chlamydia trachomatis and Neisseria gonorrhoeae (Roche cobas 4800), a fully automa

235 experiments conducted with Escherichia coli, Neisseria gonorrhoeae, Salmonella enterica, Streptococcu

236 onal locations for Chlamydia trachomatis and Neisseria gonorrhoeae screening programs.

237 During infection, Neisseria gonorrhoeae senses and responds to stress; suc

238 Previous studies have demonstrated that Neisseria gonorrhoeae sialylates the terminal N-acetylla

239 We analyzed 265 urethral Neisseria gonorrhoeae specimens collected from symptomat

240 etect Chlamydia trachomatis AC2 also detects Neisseria gonorrhoeae Storage and temperature conditions

241 Opa(+) variants of Neisseria gonorrhoeae strain FA1090 are selected in a cy

242 ding to the intact surface of the homologous Neisseria gonorrhoeae strain.

243 All Neisseria gonorrhoeae strains whose DNA sequences have b

244 Neisseria gonorrhoeae successfully overcomes host strate

245 of ceftriaxone, cefixime, and cefpodoxime in Neisseria gonorrhoeae surveillance.

246 Neisseria gonorrhoeae survives anaerobically by reducing

247 e A (gyrA) genotypic assay for prediction of Neisseria gonorrhoeae susceptibility to ciprofloxacin.

248 hes of 24 samples; for Chlamydia trachomatis/Neisseria gonorrhoeae tests, the ability to run batches

249 Whereas the structure of Neisseria gonorrhoeae Tfp has been defined by convention

250 encodes a multidrug efflux pump possessed by Neisseria gonorrhoeae that is important in the ability o

251 ous problem with antimicrobial resistance in Neisseria gonorrhoeae that the public health system face

252 or Chlamydia trachomatis and "NG" stands for Neisseria gonorrhoeae) that uses the automated m2000 mol

253 against multidrug-resistant bacteria such as Neisseria gonorrhoeae The first structure of BamA, the c

254 The Neisseria gonorrhoeae (the gonococcus [Gc]) opacity-asso

255 d exclusively by the human-specific pathogen Neisseria gonorrhoeae (the gonococcus), is characterized

256 he frequency of pilin antigenic variation in Neisseria gonorrhoeae (the gonococcus, Gc) is regulated

257 Neisseria gonorrhoeae (the gonococcus, Gc) triggers a po

258 s the gonococcal type IV pilus (GC-T4P) from Neisseria gonorrhoeae, the causative agent of gonorrhea.

259 been strongly implicated in the virulence of Neisseria gonorrhoeae, the causative agent of gonorrhea.

260 Neisseria gonorrhoeae, the causative agent of the sexual

261 Neisseria gonorrhoeae, the causative agent of the sexual

262 Neisseria gonorrhoeae, the cause of the sexually transmi

263 Neisseria gonorrhoeae, the etiologic agent of gonorrhea,

264 In Neisseria gonorrhoeae, the ferric uptake regulator Fur r

265 parallel those of Chlamydia trachomatis and Neisseria gonorrhoeae, the mechanisms by which this path

266 In the beta-proteobacterium Neisseria gonorrhoeae, the native PilQ secretin ring emb

267 reasing azithromycin usage and resistance in Neisseria gonorrhoeae threatens current dual treatment.

268 pump system that mediates the resistance of Neisseria gonorrhoeae to antimicrobial long-chain fatty

269 ression of porin 1A (Por1A) protein, enables Neisseria gonorrhoeae to bind the alternative pathway co

270 The capacity of Neisseria gonorrhoeae to cause disseminated gonococcal i

271 e sexually transmitted strict human pathogen Neisseria gonorrhoeae to mediators of the innate host de

272 years, however, development of resistance in Neisseria gonorrhoeae to multiple antimicrobial classes

273 ferrin-binding proteins TbpA and TbpB enable Neisseria gonorrhoeae to obtain iron from human transfer

274 blic health control; however, the ability of Neisseria gonorrhoeae to successively develop resistance

275 In this study, we used the type IV pilus of Neisseria gonorrhoeae to test whether variation of surfa

276 example, Candida albicans, Borrelia sp. and Neisseria gonorrhoeae) to generate surface protein diver

277 Molecular typing was used to elucidate Neisseria gonorrhoeae transmission networks among men wh

278 other STI organisms (Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis) and the E6

279 We characterized the inhibition of Neisseria gonorrhoeae type II topoisomerases gyrase and

280 c variation (Av) of the pilin subunit of the Neisseria gonorrhoeae type IV pilus.

281 The Neisseria gonorrhoeae type IV secretion system secretes

282 Neisseria gonorrhoeae uses a type IV secretion system (T

283 Neisseria gonorrhoeae uses a type IV secretion system (T

284 The obligate human pathogen Neisseria gonorrhoeae uses the MtrC-MtrD-MtrE efflux pum

285 were evaluated for Chlamydia trachomatis and Neisseria gonorrhoeae using NAATs and bacterial vaginosi

286 The strict human pathogen Neisseria gonorrhoeae utilizes homologous recombination

287 Neisseria gonorrhoeae utilizes the mtrCDE-encoded efflux

288 1 (ORF1) of the glutamine synthetase gene of Neisseria gonorrhoeae was able to tolerate urea concentr

289 lamydia trachomatis was detected in 8.7% and Neisseria gonorrhoeae was detected in 6.6%.

290 on antimicrobial resistance determinants in Neisseria gonorrhoeae was developed and is publicly acce

291 vailable assay for Chlamydia trachomatis and Neisseria gonorrhoeae was evaluated for detection of inf

292 Bacillus subtilis, Acinetobacter baylyi, and Neisseria gonorrhoeae) was experimentally verified in vi

293 Recently in Neisseria gonorrhoeae we found that mutations in three g

294 he force-dependent velocity of DNA uptake by Neisseria gonorrhoeae We found that the DNA uptake veloc

295 Tests for Chlamydia trachomatis and Neisseria gonorrhoeae, which can provide results rapidly

296 Neisseria gonorrhoeae, which causes gonorrhea, is partic

297 nd to certain biological surfaces, including Neisseria gonorrhoeae, which facilitated C3 deposition.

298 nts such as human immunodeficiency virus and Neisseria gonorrhoeae with concurrent T. vaginalis infec

299 The emergence of Neisseria gonorrhoeae with decreased susceptibility to e

300 Survival of Neisseria gonorrhoeae within host epithelial cells is ex